Empirically derived composite measures of surgical performance.

Department of Economics and the Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, New Hampshire, USA.
Medical care (Impact Factor: 2.94). 03/2009; 47(2):226-33. DOI: 10.1097/MLR.0b013e3181847574
Source: PubMed

ABSTRACT Individual quality measures have significant limitations for assessing surgical performance. Despite growing interest in composite measures, empirically-based methods for combining multiple domains of surgical quality are not well established.
To develop and validate a composite measure of surgical performance that best describes variation in hospital mortality rates and forecasts future performance.
Using the national Medicare claims database, we identified all patients undergoing aortic valve replacement in 2000 to 2001 (n = 53,120). To serve as input variables, we identified hospital-level predictors of mortality with aortic valve replacement, including hospital volume, complication rates, and mortality with other procedures. Hospital-specific predicted mortality rates were then determined using Bayesian-derived modeling techniques and assessed against subsequent hospital mortality (2002-2003).
Our composite measure explained 78% of the variation in aortic valve replacement mortality rates (2000-2001). The most important input variables were hospital volume, mortality with aortic valve replacement, and mortality for other high-risk cardiac procedures. The composite measure forecasted 70% of future hospital-level variation in mortality rates (2002-2003), and was substantially better in this regard than individual measures. Hospitals scoring in the bottom quintile on the composite measure in 2000 to 2001 had 2-fold higher mortality rates in 2002 to 2003 than hospitals in the top quintile (adjusted odds ratio, 1.97; 95% CI, 1.73-2.23).
Compared with individual surgical quality indicators, empirically derived composite measures are superior in explaining variation in hospital mortality rates and in forecasting future performance. Such measures could be useful for public reporting, value-based purchasing, or benchmarking for quality improvement purposes.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess the relationship between long-term colorectal patient survival and methods of calculating composite performance scores.
    World journal of gastroenterology : WJG. 11/2014; 20(42):15805-14.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate prognostic values of intratumoral p21-activated kinase 6 (PAK6) expression in patients with clear cell renal cell carcinoma (ccRCC). Immunohistochemistry in tissue microarray was used to evaluate the expression of PAK6 in 104 patients who had undergone nephrectomy at Zhongshan Hospital of Fudan University. Prognostic value and clinical outcomes were evaluated. Intratumoral PAK6 expression was significantly lower than nontumoral tissues (P < 0.001). Moreover, low expression of PAK6 was associated with unfavorable overall survival (OS) (P = 0.001) and recurrence-free survival (RFS) (P = 0.001). In the subgroup of patients with tumor, node, metastasis classification system (TNM) stage I + II disease, those with low expression of PAK6 were prone to have poor OS (P = 0.014) and RFS (P = 0.037). Intratumoral PAK6 low expression was correlated with tumor size (P = 0.001) and TNM stage (P = 0.006), and was identified as an independent prognostic factor for OS (hazard ratio 4.109, P = 0.002) and RFS (hazard ratio 3.175, P = 0.002). Use of an extended TNM staging system with intratumoral PAK6 expression showed a better prognostic value for OS [area under the receiver operating characteristic curve (AUC) 0.790, P = 0.022] and RFS (AUC 0.769, P = 0.040). The c-index of a Cox-based model combined with Eastern Cooperative Oncology Group performance status, TNM stage, Fuhrman grade, and PAK6 was 0.83 for OS and 0.80 for RFS. Intratumoral PAK6 could be a potential prognosticator for OS and RFS in ccRCC patients after nephrectomy. Further external validation and functional analysis should be pursued to assess its potential prognostic and therapeutic values for ccRCC patients.
    Annals of Surgical Oncology 04/2014; · 3.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate adherence to perioperative processes of care associated with major cancer resections. Mortality rates associated with major cancer resections vary across hospitals. Because mechanisms underlying such variations are not well-established, we studied adherence to perioperative care processes. There were 1,279 hospitals participating in the National Cancer DataBase (2005-2006) ranked on a composite measure of mortality for bladder, colon, esophagus, stomach, lung, and pancreas cancer operations. We sampled hospitals from among those with the lowest and highest mortality rates, with 19 low-mortality hospitals [(LMHs), risk-adjusted mortality rate of 2.84 %] and 30 high-mortality hospitals [(HMHs), risk-adjusted mortality rate of 7.37 %]. We then conducted onsite chart reviews. Using logistic regression, we examined differences in perioperative care, adjusting for patient and tumor characteristics. Compared to LMHs, HMHs were less likely to use prophylaxis against venous thromboembolism, either preoperative or postoperatively [adjusted relative risk (aRR) 0.74, 95 % CI 0.50-0.92 and aRR 0.80, 95 % CI 0.56-0.93, respectively]. The two hospital groups were indistinguishable with respect to processes aimed at preventing surgical site infections, such as the use of antibiotics prior to incision (aRR, 0.99, 95 % CI 0.90-1.04), and processes intended to prevent cardiac events, including the use of β-blockers (1.00, 95 % CI 0.81-1.14). HMHs were significantly less likely to use epidurals (aRR, 0.57, 95 % CI 0.32-0.93). HMHs and LMHs differ in several aspects of perioperative care. These areas may represent opportunities for improving cancer surgery quality at hospitals with high mortality.
    Annals of Surgical Oncology 04/2014; · 3.94 Impact Factor